Pathway analyses indicate that prostate cancer–associated fibroblasts (PCa-CAFs) are more active in pro-inflammatory and tumor-related signaling (e.g., TGF-β, NF-κB, TNF), suggesting enhanced tumor-promoting capacity. The gene discussed is NFKB1; the disease is neoplasm.